from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0145/-

LFCtreatmentdescriptionclass of inhibitor

0.308

Amikacinug/mL Amikacintranslation

0.172

Cap5-10ug/mL Capreomycintranslation

0.753

Rox10-50 ug/mL Roxithromycintranslation

1.692

SM2-5 ug/mL Streptomycintranslation

0.312

Tet5-10 ug/mL Tetracyclinetranslation

-1.364

Rif0.2-5ug/mL Rifampicintranscription

0.042

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.000

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-2.200

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.267

CPZ10-50 ug/mL Chlorpromazinerespiration

0.000

Clofazimine10-13 ug/mL Clofaziminerespiration

0.051

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.846

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.000

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-1.673

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.123

Econazole10-24 ug/mL Econazole (azole drug)respiration

-1.119

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.171

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.916

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.285

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.000

KCN5-20 ug/mL Potassium cyaniderespiration

0.032

NaN30.2-2 mM Sodium aziderespiration

-0.538

Nigericin50 uM Nigericinrespiration

-0.279

TRC10-150 ug/mL Triclosanrespiration

0.484

TRZ10-25 ug/mL Thioridazinerespiration

-1.407

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-0.093

menadione6-10 ug/mL Menadionerespiration

0.672

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.063

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.590

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-1.272

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.664

NRP_1Non-replicating persistence stage 1dosRassociated

-0.047

Amp0.2mg/mL AmpicillincellWall

0.272

Cephalexin20-100 ug/mL CephalexincellWall

0.588

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.226

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.191

EMB10-20 ug/mL EthambutolcellWall

1.146

Eta12-40 ug/mL EthionamidecellWall

1.676

INH0.2-0.4 ug/mL IsoniazidcellWall

1.550

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.000

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.000

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.573

BZA0.12 mg/mL BenzamidearomaticAmides

-0.550

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.550

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.243

H2O24 mM hydrogen peroxideDNAdamaging

-0.167

Levo10 ug/mL LevofloxacinDNAdamaging

0.892

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.584

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.071

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.491

UVUV-irradiationDNAdamaging

0.000

ARP41-4 ug/mL Antitubercular compound ARP4?

0.202

Antimycin12.5-50 ug/mL Antimycin A?

-1.439

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.153

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.231

PA_2110-50 ug/mL Antitubercular compound PA-21?

-1.041

PA8240.2-2 ug/mL PA-824?

-0.256

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.278

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-1.220

Verapamil50 uM Verapamil?

-2.183

mercaptoethanol2 mM 2-Mercaptoethanol?

-1.101

methoxatin10-20 ug/mL Methoxatin?